Fundraising FoxiSelect Fund — 2020 Investments
3 investments dated 2020 · listed companies and verified rows first · show all
Mercy BioAnalytics develops diagnostic tests for early cancer detection using advanced proteomics and genomics technologies.
BiotechDigital HealthHealthtechMedical DevicesNatick, US
Paul Blavin(Co-Founder & Vice Chairman)inStanley Lapidus(Director)inDawn Mattoon, PhD(Chief Executive Officer)Joseph Sedlak(Executive Officer, Director)
BoardPaul Meister(Director)Sonja Hoel Perkins(Director)in
Co-investorsAvestria VenturesHatteras Venture PartnersMindshift CapitalNovalis LifeSciencesPortfoliaSozo Ventures+2 more
Molecular Assemblies uses a Fully Enzymatic Synthesis (FES) technology to produce long, pure, and accurate synthetic DNA oligonucleotides, up to 400 bases, without post-synthesis purification.
BiotechDeep TechNew MaterialsSan Diego, US
J. William Efcavitch, Ph.D.(Treasurer and Chief Scientific Officer)Michael J. Kamdar(President, Chief Executive Officer and Secretary)Bill Efcavitch(Founder)Curt Becker(Founder)
BoardDavid Hwang(Director)Larry Stambaugh(Chairman of the Board of Directors)
Co-investors11.2 CapitalDCVC (Data Collective)Keshif VenturesRising TideAlexandriaArgonautic Ventures+2 more
TradeLanes provides supply chain visibility software for maritime logistics, detecting and contextualizing cargo schedule changes to enable faster operational decisions for exporters and drayage operators.
AI & Machine LearningClimate TechLogistics & Supply ChainSaaSSan Francisco, US
Co-investorsBread And Butter Ventures, LlcInnova Memphis, Inc.S2G InvestmentsTechstarsClosed Loop PartnersPrairie Crest Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.